Search alternatives:
significant challenges » significant challenge (Expand Search), significant changes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenges decrease » challenges case (Expand Search)
significant challenges » significant challenge (Expand Search), significant changes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenges decrease » challenges case (Expand Search)
-
3801
-
3802
-
3803
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3804
-
3805
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3806
-
3807
-
3808
-
3809
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3810
-
3811
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3812
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3813
-
3814
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3815
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3816
-
3817
Potential metabolites in the colonic tissue related with diarrhea induced by FSE.
Published 2025Subjects: -
3818
-
3819
-
3820
Heatmap and pathway analysis of the potential metabolites in colon tissue related with diarrhea.
Published 2025Subjects: